Safety and immunogenicity of a single dose of a quadrivalent meningococcal conjugate vaccine (MenACYW–D): a multicenter, blind-observer, randomized, phase III clinical trial in the Republic of Korea

Safety and immunogenicity of a single dose of a quadrivalent meningococcal conjugate vaccine (MenACYW–D): a multicenter, blind-observer, randomized, phase III clinical trial in the Republic of Korea

Objectives: To assess the safety and immunogenicity of a meningococcal polysaccharide diphtheria toxoid conjugate vaccine (MenACYW–D) in a Korean population. Methods: This was a phase III, blind-observer, controlled study in which participants aged 11–55 years were randomized (2:1 ratio) to a single...

Full description

Bibliographic Details
Main Authors: Dong Soo Kim, Min Ja Kim, Sung-Ho Cha, Hwang Min Kim, Jong-Hyun Kim, Kwang Nam Kim, Jin-Soo Lee, Jun Yong Choi, Valérie Bosch Castells, Hee Soo Kim, Joon Bang, Philipp Oster
Format: Article
Language:English
Published: Elsevier 2016-04-01
Series:International Journal of Infectious Diseases
Subjects:
Meningococcal vaccine
MenACYW–D
Immunogenicity
Safety
Republic of Korea
Online Access:http://www.sciencedirect.com/science/article/pii/S1201971216000308

Internet

http://www.sciencedirect.com/science/article/pii/S1201971216000308

Similar Items